Ontology highlight
ABSTRACT: Background
Genetic evaluation of cardiomyopathies poses a challenge. Multiple genes are involved but no clear genotype-phenotype correlations have been found so far. In the past, genetic evaluation for hypertrophic (HCM) and dilated (DCM) cardiomyopathies was performed by sequential screening of a very limited number of genes. Recent developments in sequencing have increased the throughput, enabling simultaneous screening of multiple genes for multiple patients in a single sequencing run.Objective
Development and implementation of a next generation sequencing (NGS) based genetic test as replacement for Sanger sequencing.Methods and results
In order to increase the number of genes that can be screened in a shorter time period, we enriched all exons of 23 of the most relevant HCM and DCM related genes using on-array multiplexed sequence capture followed by massively parallel pyrosequencing on the GS-FLX Titanium. After optimisation of array based sequence capture it was feasible to reliably detect a large panel of known and unknown variants in HCM and DCM patients, whereby the unknown variants could be confirmed by Sanger sequencing.Conclusions
The rate of detection of (pathogenic) variants in both HCM and DCM patients was increased due to a larger number of genes studied. Array based target enrichment followed by NGS showed the same accuracy as Sanger sequencing. Therefore, NGS is ready for implementation in a diagnostic setting.
SUBMITTER: Mook OR
PROVIDER: S-EPMC3756457 | biostudies-literature | 2013 Sep
REPOSITORIES: biostudies-literature
Mook Olaf R F OR Haagmans Martin A MA Soucy Jean-François JF van de Meerakker Judith B A JB Baas Frank F Jakobs Marja E ME Hofman Nynke N Christiaans Imke I Lekanne Deprez Ronald H RH Mannens Marcel M A M MM
Journal of medical genetics 20130619 9
<h4>Background</h4>Genetic evaluation of cardiomyopathies poses a challenge. Multiple genes are involved but no clear genotype-phenotype correlations have been found so far. In the past, genetic evaluation for hypertrophic (HCM) and dilated (DCM) cardiomyopathies was performed by sequential screening of a very limited number of genes. Recent developments in sequencing have increased the throughput, enabling simultaneous screening of multiple genes for multiple patients in a single sequencing run ...[more]